1. |
Cacace, R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer’s disease revisited. Alzheimers Dement, 2016, 12(6): 733-748.
|
2. |
Ayodele T, Rogaeva E, Kurup JT, et al. Early-onset Alzheimer’s disease: what is missing in research?. Curr Neurol Neurosci Rep, 2021, 21(2): 4.
|
3. |
Lanoiselée HM, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med, 2017, 14(3): e1002270.
|
4. |
Bagaria J, Bagyinszky E, An SSA. Genetics, functions, and clinical impact of presenilin-1 (PSEN1) gene. Int J Mol Sci, 2022, 23(18): 10970.
|
5. |
Zhang S, Zhang M, Cai F, et al. Biological function of Presenilin and its role in AD pathogenesis. Transl Neurodegener, 2013, 2(1): 15.
|
6. |
Chen WT, Hsieh YF, Huang YJ, et al. G206D mutation of presenilin-1 reduces Pen2 interaction, increases Aβ42/Aβ40 ratio and elevates ER Ca2+ accumulation. Mol Neurobiol, 2015, 52(3): 1835-1849.
|
7. |
Bagyinszky E, Park SA, Yan C, et al. Pathogenic PSEN1 mutation detected in a Korean EOAD patient. Alzheimers Dement, 2014, 10: 348.
|
8. |
Roh JH, Na HR, Yang DW, et al. Potential opportunities for Korean participation in the DIAN study. Alzheimer Dement, 2014, 10(4S): 815.
|
9. |
Yan C, Bagyinszky E, An SS, et al. PSEN1 L226F: a pathogenic mutation in a Korean EOAD patient. Toxicol Environ Health Sci, 2013, 5: S76.
|
10. |
Rogaeva EA, Fafel KC, Song YQ, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology, 2001, 57(4): 621-625.
|
11. |
Raux G, Guyant-Maréchal L, Martin C, et al. Molecular diagnosis of autosomal dominant early onset Alzheimer’s disease: an update. J Med Genet, 2005, 42(10): 793-795.
|
12. |
Park HK, Na DL, Lee JH, et al. Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer’s disease. J Korean Med Sci, 2008, 23(2): 213-217.
|
13. |
Liu J, Wang Q, Jing D, et al. Diagnostic approach of early-onset dementia with negative family history: implications from two cases of early-onset Alzheimer’s disease with de novo PSEN1 mutation. J Alzheimers Dis, 2019, 68(2): 551-558.
|
14. |
Snider BJ, Norton J, Coats MA, et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol, 2005, 62(12): 1821-1830.
|
15. |
Pastor P, Roe CM, Villegas A, et al. Apolipoprotein Eε4 modifies Alzheimer’s disease onset in an E280A PS1 kindred. Ann Neurol, 2003, 54(2): 163-169.
|
16. |
Mendez MF, Lee AS, Joshi A, et al. Nonamnestic presentations of early-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen, 2012, 27(6): 413-420.
|
17. |
Zhang S, Lei C, Liu P, et al. Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: a systematic review. Neurosci Biobehav Rev, 2015, 56: 180-192.
|